Dulaglutide for erectile dysfunction in type 2 diabetes

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Præsentation
Citationsformater

Madsbad, Sten

Originalsprog	Engelsk
Tidsskrift	The Lancet Diabetes and Endocrinology
Vol/bind	9
Udgave nummer	8
Sider (fra-til)	472-473
Antal sider	2
ISSN	2213-8587
DOI	https://doi.org/10.1016/S2213-8587(21)00142-X
Status	Udgivet - aug. 2021

Bibliografisk note

Funding Information:
SM is on advisory boards for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi, and Bayer, receives speaker fees from AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme, Novo Nordisk, and Sanofi, and has received research grants from Novo Nordisk and Boehringer Ingelheim.

ID: 285950615